Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
Hong Kong · Delayed Price · Currency is HKD 19.30
+0.95 (5.18%)
Sep 30, 2026, 4:08 PM HKT
HKG:1877 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,853 | 2,615 | 2,502 | 3,788 | 5,997 | 3,507 |
Short-Term Investments | - | - | - | - | 17.93 | - |
Trading Asset Securities | 963.89 | 600.78 | 430.51 | - | - | - |
Cash & Short-Term Investments | 3,816 | 3,216 | 2,933 | 3,788 | 6,015 | 3,507 |
Cash Growth | 8.82% | 9.65% | -22.58% | -37.02% | 71.53% | 3.59% |
Accounts Receivable | 743.75 | 506.75 | 509.82 | 483.23 | 232.73 | 1,301 |
Other Receivables | - | - | 36.44 | 374.01 | 78.81 | 28.05 |
Receivables | 743.75 | 506.75 | 546.26 | 857.23 | 314.25 | 1,329 |
Inventory | 498.82 | 573.11 | 584.47 | 538.05 | 599.02 | 484.6 |
Prepaid Expenses | - | - | - | - | 239.82 | - |
Other Current Assets | 146.28 | 162.01 | 220.38 | 387.59 | 36.94 | 524.79 |
Total Current Assets | 5,205 | 4,458 | 4,284 | 5,571 | 7,205 | 5,845 |
Property, Plant & Equipment | 5,126 | 4,872 | 4,195 | 3,809 | 3,278 | 2,801 |
Long-Term Investments | 2,720 | 1,914 | 1,226 | 1,133 | 1,292 | 1,485 |
Other Intangible Assets | 541.9 | 559.77 | 521.41 | 546.96 | 98.91 | 264.98 |
Long-Term Deferred Tax Assets | 86.34 | 88.31 | 87.05 | 103.4 | 228.43 | 88.55 |
Long-Term Deferred Charges | 9.38 | 9.76 | 6.12 | 12.6 | - | 27.79 |
Other Long-Term Assets | 512.78 | 480.35 | 461.94 | 167.14 | 473.39 | 522.34 |
Total Assets | 14,202 | 12,382 | 10,782 | 11,343 | 12,576 | 11,035 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 78.98 | 73.99 | 115.9 | 125.19 | 370.23 | 63.17 |
Accrued Expenses | 740.55 | 804.98 | 901.44 | 1,046 | 917.21 | 1,603 |
Short-Term Debt | 742.24 | 603.2 | 678.11 | 452.44 | 391.75 | - |
Current Portion of Long-Term Debt | 656.27 | 659.39 | 216.5 | 86.96 | - | 10.6 |
Current Portion of Leases | 43.62 | 32.01 | 30.29 | 35.93 | 43.66 | 34.47 |
Current Income Taxes Payable | 5.18 | 4.76 | 12.41 | 17.98 | - | 63.08 |
Current Unearned Revenue | 62.01 | 22.18 | 8.17 | 146.3 | 0.44 | 45.8 |
Other Current Liabilities | 562.32 | 577.77 | 531.11 | 527.92 | 50.96 | 181.59 |
Total Current Liabilities | 2,891 | 2,778 | 2,494 | 2,438 | 1,774 | 2,001 |
Long-Term Debt | 4,419 | 2,794 | 1,980 | 1,196 | 839.58 | 490 |
Long-Term Leases | 52.37 | 56.62 | 26.31 | 17.45 | 46.59 | 93.13 |
Long-Term Unearned Revenue | 157.13 | 167.17 | 181.91 | 183.46 | 121.62 | 122.46 |
Other Long-Term Liabilities | 530.08 | 530.06 | 168 | 187.15 | - | 11.5 |
Total Liabilities | 8,050 | 6,326 | 4,850 | 4,022 | 2,782 | 2,719 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,027 | 1,027 | 985.69 | 985.69 | 982.87 | 910.76 |
Additional Paid-In Capital | 16,307 | 16,417 | 15,407 | 15,395 | - | 11,423 |
Retained Earnings | -11,195 | -11,216 | -10,341 | -9,060 | - | -4,389 |
Treasury Stock | -30.89 | -30.89 | -30.89 | -26.89 | - | - |
Comprehensive Income & Other | -164.7 | -166.69 | -159.94 | -142.07 | 8,519 | 0.21 |
Total Common Equity | 5,944 | 6,030 | 5,860 | 7,151 | 9,501 | 7,945 |
Minority Interest | 207.73 | 26.16 | 71.71 | 169.39 | 292.83 | 371.28 |
Shareholders' Equity | 6,151 | 6,057 | 5,932 | 7,321 | 9,794 | 8,316 |
Total Liabilities & Equity | 14,202 | 12,382 | 10,782 | 11,343 | 12,576 | 11,035 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 5,914 | 4,145 | 2,931 | 1,789 | 1,322 | 628.19 |
Net Cash (Debt) | -2,097 | -928.98 | 1.82 | 2,000 | 4,693 | 2,878 |
Net Cash Growth | - | - | -99.91% | -57.39% | 63.05% | 13.58% |
Net Cash Per Share | -1.99 | -0.92 | 0.00 | 2.03 | 5.12 | 3.23 |
Filing Date Shares Outstanding | 1,026 | 1,026 | 984.87 | 985.01 | 982.87 | 910.76 |
Total Common Shares Outstanding | 1,026 | 1,026 | 984.87 | 985.01 | 982.87 | 910.76 |
Working Capital | 2,314 | 1,679 | 1,790 | 3,133 | 5,431 | 3,843 |
Book Value Per Share | 5.79 | 5.88 | 5.95 | 7.26 | 9.67 | 8.72 |
Tangible Book Value | 5,402 | 5,471 | 5,339 | 6,604 | 9,403 | 7,680 |
Tangible Book Value Per Share | 5.27 | 5.33 | 5.42 | 6.70 | 9.57 | 8.43 |
Buildings | 1,434 | 1,425 | 1,379 | 1,419 | - | 891.83 |
Machinery | 2,219 | 2,161 | 2,022 | 1,921 | 1,522 | 1,419 |
Construction In Progress | 2,835 | 2,572 | 1,859 | 1,325 | 1,048 | 801.93 |
Leasehold Improvements | - | - | - | - | 65.57 | - |